Pelthos Therapeutics Inc. · AMEX:PTHS

Greenleaf Peter sold 797 Pelthos Therapeutics Inc. shares (Form 4)

Traded Apr 2, 2026 · Filed Apr 6, 2026

On Apr 2, 2026, Greenleaf Peter (Director) sold 797 Pelthos Therapeutics Inc. shares at an average US$20.92 for US$16,671 under a trading plan, leaving 24,681 shares. Filed Apr 6, 2026 (Form 4).

Sold
797 shares
Price
US$20.92 average (US$20.52 to US$21.36)
Value
US$16,671
Holding after
24,681 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 2, 2026Common StockSale420US$20.5225,058Direct
Apr 2, 2026Common StockSale377US$21.3624,681Direct

Source

View original at SEC

Related